InvestSMART

Island Pharmaceuticals Limited (ASX:ILA)

ALERT: Price-sensitive ASX Announcement for ILA
Current share price for ILA : $0.450 0.075 (20%)+
Announcement
Release
3 Jul 2026 12:23PM
Price at Release
$0.375
Full Release
download
Summary
On July 3, 2026, trading in the securities of Island Pharmaceuticals Limited (ASX: ILA) was halted at the company's request. The halt was implemented in anticipation of a forthcoming announcement concerning the use of Galidesivir in a clinical trial for Ebola in Africa. As per the ASX listing rules, the halt will remain in effect until the earlier of the announcement's release or the commencement of normal trading on July 7, 2026. The request for this trading halt aims to manage disclosure obligations and maintain an orderly market. Island Pharmaceuticals confirmed no reasons or additional information should prevent the trading halt.
Key Points
  • Trading halt requested by Island Pharmaceuticals Limited (ASX: ILA)
  • Pending announcement regarding Galidesivir clinical trial in Ebola in Africa
  • Trading halt will last until the announcement release or July 7, 2026
  • Purpose of halt is to manage disclosure obligations and maintain orderly market
  • No known reasons against the trading halt
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.